Crossmark

Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin–Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity

Crossref DOI link: https://doi.org/10.1208/s12249-021-02000-2

Published Online: 2021-04-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Ying

Tang, Lei

Chen, Peng

Chen, Mei

Zheng, Miaomiao

Shi, Feng

Wang, Yanchun
License Information

Text and Data Mining valid from 2021-04-20

Version of Record valid from 2021-04-20
More Information

Article History

Received: 5 November 2020

Accepted: 22 March 2021

First Online: 20 April 2021

Disclosures

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below